Diagnosis of infectious diseases with nuclear medicine

11 Nov.,2023

 

How nuclear medicine helps diagnose infectious diseases

Both in-vivo imaging and in-vitro methods are part of the nuclear medicine tool-kit to diagnose infectious diseases. In-vitro techniques involving imaging and molecular laboratory tests help identify infections and manage drug resistance.

However, in-vivo methods such as radiolabelling white blood cells are still the gold standard technique for infection detection. This technique is based on the property of leukocytes (white blood cells) to migrate into infected areas to destroy bacteria. With this method, a sample of white blood cells is labelled with the medical radioisotope Technetium-99m and reinjected into the patient. The imaging of the areas to which the cells spread in the body – a movement called focal uptake – then allows the infected regions to be identified.

Nuclear medicine studies and magnetic resonance imaging are used in the diagnosis and follow-up of different diseases, such as osteomyelitis  (infections of the bone that may involve the entire structure down to the bone marrow); fevers of unknown origin and infected vascular prosthesis. The latter are bacterial infections that can occur during operations to replace or bypass with a graft damaged or diseased blood vessels.

Considered very challenging medical conditions,  all these infections can be caused by bacteria carried from a distant site through the bloodstream; through inoculation from direct trauma; a contiguous focus of infection; or sepsis following surgery. The diagnosis of osteomyelitis is not always obvious, and radionuclide procedures are frequently performed as part of the diagnosis.

Positron emission tomography can diagnose a variety of infections with a fairly high degree of certainty, for example large-vessel vasculitis; abdominal infections such as inflammatory bowel disease; and thoracic and soft-tissue infection. It is also useful in tumour-induced fever caused by Hodgkin’s disease; aggressive non-Hodgkin’s lymphoma; colorectal cancer; and sarcoma. In patients with fever of unknown origin, in-vitro or in-vivo labelled white-blood cells methods are of limited value because of the rather low prevalence of granulocytic processes in a clinical setting.

With high quality products and considerate service, we will work together with you to enhance your business and improve the efficiency. Please don't hesitate to contact us to get more details of Infectious Disease Test Kit.